77 related articles for article (PubMed ID: 2886569)
1. Effect of indenolol treatment on beta-adrenergic receptors of polymorphonucleates in essential hypertension.
Corradi L; Groothold G; Venco A; Mailland F; Negri F; Grandi A; Barzizza F; Finardi G
J Hypertens Suppl; 1986 Dec; 4(6):S137-40. PubMed ID: 2886569
[TBL] [Abstract][Full Text] [Related]
2. [Effects of indenolol on left ventricular mass in patients with essential arterial hypertension].
Sau F; Seguro C; Lai C; Orani E; Soro A; Onnis E; Cherchi A
Cardiologia; 1990 Nov; 35(11):925-30. PubMed ID: 2151570
[TBL] [Abstract][Full Text] [Related]
3. Indenolol kinetics versus pharmacodynamics in hypertension.
Mailland F; Groothold G; Poli A; Pantarotto C
Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):567-74. PubMed ID: 2877127
[TBL] [Abstract][Full Text] [Related]
4. Indenolol, a beta-blocker with partial agonism at vascular beta-adrenoceptors.
Taddei S; Pedrinelli R; Salvetti A
Clin Pharmacol Ther; 1989 Nov; 46(5):560-5. PubMed ID: 2573443
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of a new beta-adrenergic receptor blocking substance, indenolol].
Cirino D; Savonelli C; Maggi GC
Minerva Cardioangiol; 1983 Nov; 31(11):671-6. PubMed ID: 6142433
[No Abstract] [Full Text] [Related]
6. Decreased beta-adrenoceptors in polymorphonucleates in essential hypertension.
Corradi L; Negri F; Parini A; Partesana N; Finardi G
Boll Soc Ital Biol Sper; 1981 Sep; 57(17):1766-70. PubMed ID: 6272827
[TBL] [Abstract][Full Text] [Related]
7. Computerized echocardiographic study of left ventricular function and cardiodynamic investigation with a new antihypertensive agent (indenolol).
Venco A; Groothold G; Grandi A; Barzizza F; Corradi L; Negri F; Finardi G
Clin Ther; 1985; 7(3):347-56. PubMed ID: 3995529
[TBL] [Abstract][Full Text] [Related]
8. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
Poggesi L; Bisi G; La Cava G; Sciagra R; Del Rosso A; Masotti G
J Clin Pharmacol; 1995 Feb; 35(2):176-81. PubMed ID: 7751429
[TBL] [Abstract][Full Text] [Related]
9. [Potential use of indenolol in hypertensive patients with chronic bronchial asthma].
Della Toffola A; Galietti F; Giorgis GE; Miravalle C; Oliaro A; Palazzo F; Scappaticci E
Minerva Med; 1986 Oct; 77(39):1819-21. PubMed ID: 3534631
[TBL] [Abstract][Full Text] [Related]
10. Changes in left ventricular anatomy and systemic hemodynamics induced by antihypertensive therapy with indenolol.
De Luca N; Ricciardelli B; Groothold G; Cuocolo A; Volpe M; Trimarco B
J Clin Hypertens; 1987 Jun; 3(2):125-34. PubMed ID: 2956371
[TBL] [Abstract][Full Text] [Related]
11. Effects of prolonged administration of indenolol in hypertensive rats.
Kato H; Kurihara J; Takata Y; Kunugi H; Miyajima Y
Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):82-95. PubMed ID: 6138007
[TBL] [Abstract][Full Text] [Related]
12. Acute and long-term haemodynamic effects of propranolol and indenolol in hypertension.
Malacco E; Mailland F; Bosisio E; Meroni R; Dagani R; Renesto E; Bevilacqua M
Eur J Clin Pharmacol; 1986; 30(2):157-60. PubMed ID: 3709639
[TBL] [Abstract][Full Text] [Related]
13. Changes in lymphocyte beta-adrenoceptor density after dilevalol oral treatment.
Sbirrazzuoli V; Drici M; Garraffo R; Candito M; Gibelin P; Morand P; Lapalus P
Drugs Exp Clin Res; 1989; 15(5):223-9. PubMed ID: 2551622
[TBL] [Abstract][Full Text] [Related]
14. [Activity and number of lymphocyte beta adrenergic receptors after protracted treatment with mepindolol sulfate of patients with essential arterial hypertension].
Fabris B; De Biasi F; Fischetti F; Leprini R; Castellano M; Carretta R
G Clin Med; 1990 Nov; 71(11):639-44. PubMed ID: 1964919
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a vasodilating beta-blocker and a cardioselective beta-blocker in long-term treatment of hypertension: a European multicentre study.
Ambrosioni E; Birkenhäger W; De Leeuw PW; Dal Palù C; Demanet JC; Groothold G; Libretti A; Mailland F; Malacco E; Poli A
J Hypertens Suppl; 1989 Dec; 7(6):S266-7. PubMed ID: 2576667
[TBL] [Abstract][Full Text] [Related]
16. [Effect of a beta 2-blocker on the adrenergic receptors of lymphocytes in hypertension].
Krasnikova TL; Radiukhin VA; Parfenova EV; Suvorov IuI; Ustinova SE
Biull Eksp Biol Med; 1986 Jul; 102(7):46-8. PubMed ID: 2873850
[TBL] [Abstract][Full Text] [Related]
17. Effects of indenolol (YB-2), a new beta-adrenergic blocking agent, and its dextro isomer on the central nervous system of mice and rabbits.
Tachikawa S; Takenaka T; Maeno H
Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):74-87. PubMed ID: 30422
[TBL] [Abstract][Full Text] [Related]
18. Indenolol: a new antihypertensive agent: efficacy, toxicity, and hemodynamic effects in a crossover double-blind study with metoprolol.
Trimarco B; Cuocolo A; Groothold G; Ricciardelli B; De Luca N; Volpe M; Veniero AM; Condorelli M
J Clin Pharmacol; 1985; 25(5):328-36. PubMed ID: 4031109
[TBL] [Abstract][Full Text] [Related]
19. Indenolol in hypertension.
Sega R; Mailland F; Damiani E; Groothold G; Libretti A
Clin Pharmacol Ther; 1983 Mar; 33(3):289-93. PubMed ID: 6337761
[TBL] [Abstract][Full Text] [Related]
20. Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
Nederfors T
Swed Dent J Suppl; 1996; 116():1-70. PubMed ID: 8813731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
